Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.81	52.43	26.67	33.51	25.18	44.35
Short-Term Investments	-	-	-	-	-	2.5
Cash & Short-Term Investments	49.81	52.43	26.67	33.51	25.18	46.85
Cash Growth	66.63%	96.56%	-20.41%	33.10%	-46.27%	-40.96%
Accounts Receivable	22.76	31.08	19.59	15.16	17.14	1.82
Other Receivables	4.05	5.87	9.56	1.68	-	-
Total Trade Receivables	26.81	36.95	29.15	16.84	17.14	1.82
Inventory	-	-	-	4.28	6.12	-
Other Current Assets	3.76	2.83	2.63	2.59	1.22	2.81
Total Current Assets	91.73	102.37	64.79	57.22	49.65	51.48
Net Property, Plant & Equipment	23.57	24.73	25.7	23.76	18.38	3.71
Other Intangible Assets	4.63	4.73	0.27	0.21	0.3	-
Other Long-Term Assets	42.08	34.31	34.65	11.91	16.43	0.47
Total Assets	162.02	166.13	125.41	116.54	84.75	55.66
Accounts Payable	0.27	0.12	0.11	0.36	0.12	6.42
Accrued Expenses	15.42	14.35	10.62	11.94	9.26	5.54
Current Portion of Leases	0.75	0.64	0.71	0.21	0.49	1.98
Unearned Revenue	-	0.01	0.06	0.04	0.15	0.23
Other Current Liabilities	3.36	3.17	8.02	7.51	2.22	-
Total Current Liabilities	19.79	18.29	19.52	20.05	12.24	14.17
Long-Term Leases	0.07	0.3	0.89	0.2	0.12	0.41
Other Long-Term Liabilities	5.17	5.26	6.6	17.82	0.17	-
Total Long-Term Liabilities	5.24	5.56	7.49	18.02	0.29	0.41
Total Liabilities	25.03	23.85	27	38.07	12.54	14.57
Common Stock	0.09	0.09	0.09	0.08	0.06	0.03
Additional Paid-in Capital	174.65	172.05	136.19	68.18	32.8	443.75
Accumulated Other Comprehensive Income	0.59	-0.78	-2.6	-1.64	-0.39	-
Retained Earnings	-74.02	-65.33	-70.36	-82.44	10.06	-402.69
Total Common Shareholders' Equity	101.31	106.03	63.32	-15.83	42.52	41.09
Minority Interest	35.68	36.25	35.08	94.3	29.7	-
Shareholders' Equity	136.99	142.28	98.4	13.95	72.22	41.09
Total Liabilities & Equity	162.02	166.13	125.41	116.54	84.75	55.66
Total Debt	0.82	0.94	1.6	0.41	0.61	2.39
Net Cash (Debt)	48.99	51.49	25.07	33.1	24.56	44.47
Net Cash Growth	-4.86%	105.34%	-24.25%	34.76%	-44.76%	-42.78%
Net Cash Per Share	0.50	0.50	0.24	0.50	0.33	0.67
Book Value	101.31	106.03	63.32	-15.83	42.52	41.09
Book Value Per Share	1.04	1.03	0.62	-0.24	0.56	0.62
Tangible Book Value	96.68	101.3	63.05	-16.03	42.23	41.09
Tangible Book Value Per Share	0.99	0.98	0.62	-0.24	0.56	0.62

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q